Trials / Completed
CompletedNCT01770951
A Retrospective, Observational, Non-interventional Trial to Assess Eculizumab Treatment Effect in Patients With Atypical Hemolytic Uremic Syndrome (aHUS)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- Alexion Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The objective of this retrospective trial is to assess safety and efficacy of eculizumab in aHUS patients treated outside of an Alexion-sponsored controlled clinical trial.
Conditions
Timeline
- Start date
- 2009-08-31
- Primary completion
- 2010-11-30
- Completion
- 2010-11-30
- First posted
- 2013-01-18
- Last updated
- 2023-08-18
Locations
23 sites across 8 countries: United States, Austria, Canada, France, Germany, Netherlands, Spain, Switzerland
Source: ClinicalTrials.gov record NCT01770951. Inclusion in this directory is not an endorsement.